Title | Type | ![]() |
H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Cancer Drug Targets | journal | 2.308 Q1 | 96 | 71 | 172 | 7181 | 852 | 165 | 4.54 | 101.14 | ![]() |
2 | CNS and Neurological Disorders - Drug Targets | journal | 2.186 Q1 | 90 | 50 | 163 | 7211 | 820 | 145 | 4.88 | 144.22 | ![]() |
3 | Current Medicinal Chemistry | journal | 1.900 Q1 | 183 | 257 | 694 | 34995 | 3898 | 687 | 5.30 | 136.17 | ![]() |
4 | Current Topics in Medicinal Chemistry | journal | 1.705 Q1 | 122 | 164 | 473 | 11874 | 1957 | 410 | 3.99 | 72.40 | ![]() |
5 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.659 Q1 | 100 | 83 | 146 | 8934 | 734 | 138 | 4.48 | 107.64 | ![]() |
6 | Current Pharmaceutical Design![]() | journal | 1.642 Q1 | 166 | 370 | 1041 | 42030 | 4611 | 928 | 4.44 | 113.59 | ![]() |
7 | Current Drug Targets | journal | 1.622 Q1 | 107 | 129 | 390 | 11694 | 1674 | 349 | 4.36 | 90.65 | ![]() |
8 | Current Gene Therapy | journal | 1.597 Q1 | 75 | 41 | 146 | 4914 | 697 | 142 | 4.41 | 119.85 | ![]() |
9 | Current Vascular Pharmacology | journal | 1.168 Q1 | 63 | 39 | 112 | 4021 | 434 | 106 | 3.83 | 103.10 | ![]() |
10 | Infectious Disorders - Drug Targets | journal | 1.121 Q1 | 55 | 34 | 93 | 2979 | 274 | 86 | 3.27 | 87.62 | ![]() |
11 | Mini-Reviews in Medicinal Chemistry | journal | 1.107 Q1 | 95 | 139 | 354 | 14230 | 1186 | 345 | 3.32 | 102.37 | ![]() |
12 | Inflammation and Allergy - Drug Targets | journal | 1.085 Q2 | 51 | 35 | 62 | 3477 | 155 | 57 | 2.50 | 99.34 | ![]() |
13 | Current Drug Delivery | journal | 1.055 Q1 | 65 | 45 | 126 | 2393 | 416 | 124 | 2.94 | 53.18 | ![]() |
14 | Current Nanoscience | journal | 1.043 Q1 | 47 | 51 | 74 | 3269 | 187 | 71 | 2.53 | 64.10 | ![]() |
15 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.786 Q2 | 42 | 32 | 109 | 3255 | 286 | 104 | 2.40 | 101.72 | ![]() |
16 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.730 Q2 | 40 | 35 | 102 | 4756 | 209 | 102 | 2.09 | 135.89 | ![]() |
17 | Medicinal Chemistry | journal | 0.632 Q2 | 46 | 75 | 206 | 2780 | 447 | 206 | 2.05 | 37.07 | ![]() |
18 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.627 Q2 | 46 | 23 | 49 | 2218 | 112 | 49 | 2.29 | 96.43 | ![]() |
19 | Combinatorial Chemistry and High Throughput Screening | journal | 0.561 Q2 | 66 | 84 | 260 | 5360 | 558 | 237 | 1.85 | 63.81 | ![]() |
20 | Recent Patents on CNS Drug Discovery | journal | 0.492 Q3 | 34 | 23 | 47 | 2346 | 75 | 47 | 1.60 | 102.00 | ![]() |
21 | Current Neuropharmacology | journal | 0.467 Q3 | 82 | 26 | 78 | 5205 | 83 | 75 | 1.18 | 200.19 | ![]() |
22 | Current Drug Discovery Technologies | journal | 0.438 Q3 | 44 | 39 | 71 | 2701 | 140 | 69 | 1.84 | 69.26 | ![]() |
23 | Current Pharmaceutical Analysis | journal | 0.420 Q2 | 25 | 27 | 60 | 2132 | 67 | 60 | 1.12 | 78.96 | ![]() |
24 | Frontiers in Drug Design and Discovery | book series | 0.362 Q2 | 9 | 0 | 41 | 0 | 27 | 39 | 0.66 | 0.00 | ![]() |
25 | Current Computer-Aided Drug Design | journal | 0.361 Q3 | 31 | 30 | 52 | 2612 | 63 | 48 | 1.21 | 87.07 | ![]() |
26 | Anti-Infective Agents | journal | 0.348 Q3 | 24 | 25 | 75 | 2377 | 72 | 70 | 0.85 | 95.08 | ![]() |
27 | Letters in Drug Design and Discovery | journal | 0.302 Q2 | 35 | 86 | 312 | 2044 | 220 | 312 | 0.71 | 23.77 | ![]() |
28 | Current Clinical Pharmacology | journal | 0.289 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | ![]() |
29 | Current Enzyme Inhibition | journal | 0.267 Q3 | 18 | 20 | 54 | 1890 | 42 | 54 | 0.78 | 94.50 | ![]() |
30 | Current Drug Therapy | journal | 0.259 Q2 | 17 | 20 | 30 | 2194 | 20 | 28 | 0.67 | 109.70 | ![]() |
31 | Recent Patents on Drug Delivery and Formulation | journal | 0.246 Q2 | 36 | 22 | 22 | 2485 | 18 | 22 | 0.82 | 112.95 | ![]() |
32 | Reviews on Recent Clinical Trials | journal | 0.235 Q3 | 32 | 26 | 59 | 2055 | 39 | 55 | 0.66 | 79.04 | ![]() |
33 | Current Bioactive Compounds | journal | 0.201 Q3 | 27 | 25 | 17 | 1887 | 13 | 16 | 0.76 | 75.48 | ![]() |
34 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.189 Q3 | 14 | 48 | 77 | 5042 | 24 | 68 | 0.31 | 105.04 | ![]() |
35 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.170 Q3 | 24 | 38 | 145 | 3137 | 36 | 129 | 0.24 | 82.55 | ![]() |
36 | Drug Metabolism Letters | journal | 0.154 Q3 | 28 | 48 | 53 | 1355 | 23 | 52 | 0.43 | 28.23 | ![]() |
37 | Current Drug Safety | journal | 0.146 Q4 | 37 | 33 | 63 | 1626 | 26 | 62 | 0.41 | 49.27 | ![]() |
38 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.142 Q4 | 29 | 27 | 28 | 2069 | 11 | 28 | 0.39 | 76.63 | ![]() |
39 | Saudi Pharmaceutical Journal![]() | journal | 0.142 Q3 | 57 | 31 | 78 | 1077 | 10 | 78 | 0.13 | 34.74 | ![]() |
40 | Bulletin of Pharmaceutical Sciences | journal | 8 | 25 | 0 | 700 | 0 | 0 | 0.00 | 28.00 | ![]() | |
41 | Current Molecular Pharmacology | journal | 42 | 23 | 0 | 2979 | 0 | 0 | 0.00 | 129.52 | ![]() | |
42 | Current Pharmacogenomics and Personalized Medicine | journal | 19 | 26 | 0 | 2826 | 0 | 0 | 0.00 | 108.69 | ![]() | |
43 | Current Reviews in Clinical and Experimental Pharmacology | journal | 43 | 24 | 51 | 1878 | 49 | 51 | 0.96 | 78.25 | ![]() | |
44 | Recent Advances in Anti-Infective Drug Discovery | journal | 33 | 22 | 52 | 1985 | 67 | 52 | 1.29 | 90.23 | ![]() | |
45 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 25 | 25 | 0 | 2328 | 0 | 0 | 0.00 | 93.12 | ![]() |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®